Abstract
Many frontline healthcare workers throughout the world have been exposed to COVID-19 infection in the workplace and the community. We describe the nature of infection and the durability of antibodies among various types of healthcare workers at an acute care community hospital in northern New Jersey adjacent to New York City, part of the epicenter of the first wave of the US epidemic. Exposure was concentrated among frontline workers and in clusters among support staff. The antibody response correlated with symptoms and job type.
Methods Employees had Polymerase Chain Reaction testing using a variety of commercially available products based on availability. All screening and testing for diagnosis used the nasopharyngeal swab. Tests for SARS-CoV-2 were obtained at approximately 2, 3 and 4 months using Abbott IgG antibody assay. Results of community sero-prevalence were obtained from hospital and physician surveys as no government entity was monitoring sero-prevalence. Hospital associated employee COVID-19 infections were identified through testing and contact tracing.
Results 5179 patients with COVID-19 syndrome were managed through telehealth over 6 months. 3236 patients were admitted with COVID-19 disease during this time. 2514 out of 3100 employees were tested for antibody to SARS-CoV-2. Overall, 16% of employees tested positive for antibodies at some point. When divided by general job type, 17% of direct caregivers were positive. 16% of indirect contact such as receptionists, housekeeping and food service workers were positive. 16% of nonclinical workers with no patient contact tested positive. The community rate of sero-positivity in one study in Bergen County was 12.2. (1) In the midst of the epidemic, the rate among hospital workers in New York City was 13.7%. (2) The overall population rate in New York City, at the peak of the epidemic, was 21% with some communities as high as 68%. Long Island had 16.7% and Westchester/Rockland 11.7%. (3) Other hospital systems in Northern NJ had up to 25% sero-positive employees. (4)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Holy Name Medical Center, Investigative Committee on Clinical Research (ICCR)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
(1) bergencountyhealth.gov Bergen County Mobile Testing Statistics and Locations July 2, 2020 (2) Moscola J et al. Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in New York City Area. JAMA. 2020; 324:893-5. DOI:10.1001 (3) Goldstein J. 1.5 Million Tests Show What Parts of NYC Were Hit Hardest. NYT, Aug 19,2020 (4) Personal communication (5) Gandi M et al. Masks do more than protect others during COVID-19: reducing the inoculum of SARS-CoV-2 to protect the wearer. J Gen Intern Med 2020July 31 (Epub ahead of print) (6) Ibarrondo JF et al. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19. NEJM 2020 Jul 21, DOI: 10.1056
